Elocann

Elocann is rated 3 out of 5 in the category pharmaceuticals. Read and write reviews about Elocann. As the rapidly emerging medical cannabis is primed for growth, there is a need for controlled pharmaceutical grade production with an advanced indoor cultivation facility. Elocann drives innovation to the Medical Cannabis industry with a strong commitment to developing advanced pharmaceutical grade indoor facility for growing and manufacturing high quality medicinal cannabis products. Elocann closely collaborates with a group of leading clinical researchers and is strategically positioned to work in an ecosystem of startups and research facilities focused on various facets of Medical Cannabis. Elocann is owned by strategic partners, including: • CTS group is one of the most prominent pharmaceutical brands in Israel engaging in healthcare, crop science and animal care since 1921. • The Giving Tree Arizona has extensive experience in growing, producing and marketing medical cannabis products in Arizona, USA. Involved in every phase of medical cannabis production from field to dispensary; from growing to marketing; and from science to helping people live a better life. • Kibbutz Yakum, an agricultural cooperative, has extensive experience in agrotechnology growth, environmental conditions and plant protection. Elocann is well positioned to cultivate, develop and provide pharmaceutical grade medical cannabis products. It is aimed at providing strictly controlled agricultural and manufacturing processes, together with medical guidelines, promising patients in Europe and around the world consistent quality, trusted pharma-grade products suited to specific needs.